Last €64.43 EUR
Change Today +1.82 / 2.91%
Volume 526.0
SYK On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 2:10 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

2825 Airview Boulevard

Kalamazoo, MI 49002

United States

Phone: 269-385-2600

Fax: 269-385-1062

Stryker Corporation operates as a medical technology company worldwide. The company operates through three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Reconstructive This segment’s products consist primarily of implants used in hip and knee joint replacements and trauma and extremities surgeries. In 2013, the company acquired MAKO Surgical Corp. In 2013, the company acquired Trauson Holdings Company Limited (Trauson). The acquisition of Trauson would enhance its product offerings, primarily within its Reconstructive segment, broaden its presence in China and enable it to expand into the value segment of the emerging markets. In 2013, the company launched the Tritanium Cementless Baseplate for its Triathlon Knee System (TKA), which combines biologic fixation with Triathlon’s ideal kinematics to provide surgeons with an option for cement less TKA. The company also launched the Secur-Fit Advanced Femoral Hip Stem targeted at restoring biomechanics by leveraging its Stryker Orthopaedics Modeling and Analytics system. In 2012, the company launched Accolade II, the first hip stem with a Morphometric Wedge design, an evolution of the tapered wedge stem. The company owns Memometal Technologies, which develops, manufactures and markets products for extremity (hand and foot) indications that enhance the offerings in its trauma and extremities product line. Competition: The company competes with Zimmer Holdings, Inc. (Zimmer); DePuy Synthes Company (DePuy Synthes, a subsidiary of Johnson & Johnson); Biomet, Inc.; and Smith & Nephew plc. MedSurg This segment’s products include surgical equipment and surgical navigation systems; endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (medical); and reprocessed and remanufactured medical devices, as well as other medical device products used in various medical specialties. In 2013, the company received 510(k) clearance to market a modified Neptune 2 Waste Management System. The Neptune 2 Waste Management System mitigates risk to healthcare workers by eliminating harmful exposure to fluids and smoke in the operating room. In 2012, the company launched System 7, the next generation of heavy duty surgical power tools. These tools are used in total joint procedures, such as hip and knee replacements, and offer the latest in advanced cutting technology. The company also launched the 1488 HD 3-Chip Endoscopic Camera System, which utilizes CMOS technology and premium optics to provide a clear bright image designed to improve patient outcomes. In addition, it launched Power-LOAD, its cot fastener system that lifts and lowers the cot into and out of ambulances, thereby reducing spinal loads and the risk of cumulative trauma injuries to emergency responders. Competition: The company competes with Zimmer, Medtronic, Inc.; Conmed Linvatec, Inc. (a subsidiary of CONMED Corporation); Aesculap-Werke AG (a division of B. Braun Melsungen AG); Smith & Nephew Endoscopy (a division of Smith & Nephew plc); ConMed Linvatec, Inc.; Arthrex, Inc.; Karl Storz GmbH & Co.; Olympus Optical Co. Ltd.; Medical are Hill-Rom Holdings, Inc;. and Kinetic Concepts, Inc. Neurotechnology and Spine This segment’s products include both neurosurgical and neurovascular devices. Its neurotechnology offering includes products used for endovascular techniques; a line of products for traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. The company also develops, manufactures, and markets spinal implant products, including cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. In 2012, the company received 510(k) clearance to market the Trevo Pro Retriever, its next generation clot removal technology that utilizes proprietary Stentriever Technology for optimized clot integration and retrieval in patients experiencing acute ischemic stroke. In addition, it received 510(k)

Page 12Next Page
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SYK:GR €64.43 EUR +1.82

SYK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $68.65 USD +0.71
Becton Dickinson and Co $123.31 USD +0.65
Covidien PLC $89.25 USD +3.81
Ecolab Inc $112.70 USD +2.75
St Jude Medical Inc $59.99 USD +1.03
View Industry Companies
 

Industry Analysis

SYK

Industry Average

Valuation SYK Industry Range
Price/Earnings 48.4x
Price/Sales 3.2x
Price/Book 3.6x
Price/Cash Flow 37.4x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STRYKER CORP, please visit www.strykercorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.